Client: Peter McCallum Cancer Centre | Trans Tasman Radiation Oncology Group (TROG)

Context: This trial is trying to understand if Stereotactic radiotherapy could work as an effective treatment for patients with Oligoprogressive ER-positive Breast Cancer (ER-positive, HER2-negative advanced breast cancer) that have had partial response to prior treatment.

For more information, see:

AVATAR clincal trial infographic design context schema and outcomes